Featured

  • September 19, 2023
  • North America
  • Healthcare

Rising Pharmaceuticals Bolsters U.S. Supply Chain by Expanding Sterile Dosage Capabilities, Including Injectables and Ophthalmics, with Opening of New Facility

EAST BRUNSWICK, N.J. – September 19, 2023 – Rising Pharma Holdings Inc., dba as Rising Pharmaceuticals, today announced the opening of a commercial manufacturing facility in Decatur, Illinois, to manufacture and package sterile products, including injectables and ophthalmic products in…

Read More

  • September 7, 2023
  • North America
  • Healthcare

Click Therapeutics Announces Collaboration with Indivior to Develop and Commercialize Novel Prescription Digital Therapeutics in Substance Use Disorders

NEW YORK – September 7, 2023 – Click Therapeutics today announced the execution of a new collaboration agreement with Indivior for the development and commercialization of prescription digital therapeutics to treat substance use disorders, beginning with Opioid Use Disorder (OUD). Through a…

Read More

All Releases

Reset Filters

  • August 23, 2023
  • North America
  • Healthcare

Leiters Health Ranks No. 2069 on the 2023 Inc. 5000

NEW YORK – August 23, 2023 – Inc. revealed today that Leiters Health ranks No. 2069 on the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful …

Read More

  • July 31, 2023

Augmedics strengthens AR/AI portfolio with planned acquisition of Surgalign digital health assets

CHICAGO – July 31, 2023 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process. The …

Read More

  • July 3, 2023

Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution

BRIDGEWATER, NJ – July 3, 2023 – Nevakar Injectables Inc. (“Nevakar”), a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, announced today that the U.S. Food and Drug Administration (“FDA”) has approved …

Read More

  • June 7, 2023

Augmedics raises $82.5 million to accelerate adoption of augmented reality spine surgery

CHICAGO – June 27, 2023 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced the successful close of an $82.5 million Series D financing. The round was led by Dallas-based CPMG and adds Evidity Health Capital as …

Read More

  • May 4, 2023

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication

ROSEMONT, ILLINOIS – May 4, 2023 – Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar Injectables, Inc. This manufactured, ready-to-use formulation is room-temperature stable and will be available in three commonly administered …

Read More

  • November 3, 2022
  • North America
  • Business Services

H.I.G. Capital Completes Acquisition of Celerion

MIAMI – November 3, 2022 – H.I.G. Capital (“H.I.G.”), a leading global investment firm with $52 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the acquisition of Celerion Holdings, Inc. (“Celerion” or …

Read More

  • September 13, 2022
  • North America

H.I.G. Capital Completes Recapitalization of Navitas Life Sciences

MIAMI – September 13, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the recapitalization of Navitas Life Sciences …

Read More

  • June 29, 2022
  • North America

Leiters Joins the End Drug Shortages Alliance

DENVER – June 29, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The …

Read More

  • June 9, 2022
  • North America

Memorial Hermann Health System Joins Existing Investors in Leiters, a 503B Outsourced Pharmaceutical Compounding Industry Leader

DENVER – June 9, 2022 – Today Leiters has announced that Memorial Hermann Health System – a non-profit, community-focused, award-winning health system committed to creating healthier Houston communities – has joined the company’s growing list of strategic health system investor …

Read More

  • April 28, 2022
  • North America

Nevakar Injectables Receives U.S. FDA Approval of Ready-to-Use Ephedrine Injection in a Prefilled Syringe

BRIDGEWATER, NJ – April 28, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, and announced today that …

Read More

Displaying 10 of 191 News Articles

×